315 related articles for article (PubMed ID: 33257483)
1. Safety and efficacy of mycophenolate mofetil in treating neuromyelitis optica spectrum disorders: a protocol for systematic review and meta-analysis.
Han M; Nong L; Liu Z; Chen Y; Chen Y; Meng H; Qin Y; Wang Z; Jin M
BMJ Open; 2020 Nov; 10(11):e040371. PubMed ID: 33257483
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of plasma exchange for the treatment of optic neuritis in neuromyelitis optica spectrum disorders: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Hao L; Wang Z
Medicine (Baltimore); 2020 Jul; 99(28):e21067. PubMed ID: 32664124
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Ma J; Yu H; Wang H; Zhang X; Feng K
J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and safety of Chinese medicines for the treatment of uveitis: A protocol for systematic review and meta-analysis.
Han M; Chen Y; Nong L; Liu Z; Qin Y; Meng H; Chen Y; Wang Z; Jin M
Medicine (Baltimore); 2020 Jun; 99(26):e20766. PubMed ID: 32590753
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Wang Y; Ma J; Chang H; Zhang X; Yin L
Mult Scler Relat Disord; 2021 Oct; 55():103181. PubMed ID: 34365314
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.
Huh SY; Kim SH; Hyun JW; Joung AR; Park MS; Kim BJ; Kim HJ
JAMA Neurol; 2014 Nov; 71(11):1372-8. PubMed ID: 25199960
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Chinese medicines for vitreous hemorrhage: A protocol for systematic review and meta-analysis.
Han M; Liu Z; Nong L; Zi Y; Meng H; Deng Y; Wang ZJ; Jin M
Medicine (Baltimore); 2020 May; 99(19):e20086. PubMed ID: 32384479
[TBL] [Abstract][Full Text] [Related]
8. Dose effects of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum disorders: a case series study.
Jiao Y; Cui L; Zhang W; Zhang C; Zhang Y; Zhang X; Jiao J
BMC Neurol; 2018 Apr; 18(1):47. PubMed ID: 29688841
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.
Songwisit S; Kosiyakul P; Jitprapaikulsan J; Prayoonwiwat N; Ungprasert P; Siritho S
Sci Rep; 2020 Oct; 10(1):16727. PubMed ID: 33028926
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Chen H; Qiu W; Zhang Q; Wang J; Shi Z; Liu J; Lian Z; Feng H; Miao X; Zhou H
Eur J Neurol; 2017 Jan; 24(1):219-226. PubMed ID: 27783452
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients.
Pathomrattanapiban C; Tisavipat N; Jitprapaikulsan J; Prayoonwiwat N; Rattanathamsakul N; Siritho S
Mult Scler Relat Disord; 2022 Jul; 63():103882. PubMed ID: 35598463
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
Chen H; Zhang Y; Shi Z; Feng H; Yao S; Xie J; Zhou H
Clin Neuropharmacol; 2016; 39(2):81-7. PubMed ID: 26818042
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Immunosuppressive Drug Therapy for Neuromyelitis Optica Spectrum Disorders: An Overview of Meta-Analyses and Systematic Reviews.
Luo Y; Deng Y; Ran H; Yu L; Ma C; Zhao L; Li Y
Curr Neuropharmacol; 2023; 21(8):1827-1834. PubMed ID: 36154604
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.
Espiritu AI; Pasco PMD
Mult Scler Relat Disord; 2019 Aug; 33():22-32. PubMed ID: 31136907
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study.
Xu Y; Wang Q; Ren HT; Qiao L; Zhang Y; Fei YY; Zhao Y; Cui LY
J Neurol Sci; 2016 Nov; 370():224-228. PubMed ID: 27772764
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture for patients with chronic pruritus: protocol of a systematic review and meta-analysis.
Zhang L; Deng Y; Yao J; Xiao X; Yu S; Shi Y; Zheng H; Zheng Q; Zhou S; Cao W; Liu Y; Hao P; Li Y
BMJ Open; 2020 Aug; 10(8):e034784. PubMed ID: 32819932
[TBL] [Abstract][Full Text] [Related]
17. Effect of perioperative intravenous lidocaine on postoperative outcomes in patients undergoing resection of colorectal cancer: a protocol for systematic review and meta-analysis.
Ji W; Zhang X; Sun G; Wang X; Liu J; Bian J; Bo L
BMJ Open; 2021 Aug; 11(8):e048803. PubMed ID: 34426465
[TBL] [Abstract][Full Text] [Related]
18. Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis.
Yin Z; Qiu Y; Duan A; Fang T; Chen Z; Wu J; Wang Z; Chen G
J Neurol; 2023 Jun; 270(6):2950-2963. PubMed ID: 36884069
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of azathioprine, mycophenolate mofetil, and rituximab in the treatment of neuromyelitis optica spectrum disorder and analysis of prognostic factors.
Zhang L; Tian J; Dong X; Jia Z; Sun Y; Guo L; Tan G; Li B
Neurol Sci; 2022 Apr; 43(4):2651-2658. PubMed ID: 34585292
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
Montcuquet A; Collongues N; Papeix C; Zephir H; Audoin B; Laplaud D; Bourre B; Brochet B; Camdessanche JP; Labauge P; Moreau T; Brassat D; Stankoff B; de Seze J; Vukusic S; Marignier R;
Mult Scler; 2017 Sep; 23(10):1377-1384. PubMed ID: 27885065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]